Keyphrases
Angiotensin II (Ang II)
66%
Angiotensin II Type 1 Receptor (AT1R)
33%
Angiotensin Receptor Antagonists
100%
Angiotensin-converting Enzyme Inhibition
66%
Angiotensin-converting Enzyme Inhibitor (ACEi)
100%
AT-1
66%
AT2 Receptor
66%
Cell Differentiation
33%
Cell Infiltration
33%
Cell Proliferation
33%
Clusterin
66%
Etiology
33%
Fibroblast Proliferation
66%
Fibroblasts
33%
Fibrotic Process
33%
Inflammation
33%
Inflammatory Fibrosis
33%
Kidney
33%
Kidney Disease
66%
Kidney Disease Progression
33%
Macrophage Infiltration
66%
Monocyte Infiltration
33%
Monocyte-derived Macrophages
66%
Myofibroblast
66%
Myofibroblast Proliferation
33%
Nuclear factor-κB
100%
Pathophysiologic
33%
Pharmacologic Effects
33%
Profibrotic Cytokines
33%
Receptor Blockade
66%
Renal Function
33%
Scar
100%
TGF-1
33%
Therapeutic Potential
33%
Transcription Factor
66%
Transforming Growth Factor-β
66%
Tubular Injury
33%
Tubulointerstitial Fibrosis
33%
Medicine and Dentistry
ACE Inhibitor
100%
Angiotensin II
66%
Angiotensin Receptor
33%
Angiotensin Receptor Antagonist
100%
Cell Differentiation
33%
Cell Proliferation
33%
Cellular Infiltration
33%
Clusterin
66%
Cytokine
33%
Dipeptidyl Carboxypeptidase
66%
Disease Exacerbation
33%
Enzyme Inhibition
66%
Fibrinogen
66%
Fibroblast
100%
Fibrosis
66%
Immunoglobulin Enhancer Binding Protein
100%
Kidney Function
33%
Macrophage
66%
Monocyte
100%
Myofibroblast
100%
Nephropathy
100%
Receptor Blocking
66%
Scar Formation
100%
Transcription Factors
66%
Transforming Growth Factor
66%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin II
66%
Angiotensin Receptor
33%
Angiotensin Receptor Antagonist
100%
Clusterin
66%
Cytokine
33%
Dipeptidyl Carboxypeptidase
66%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Disease Exacerbation
33%
Enzyme Inhibition
66%
Fibrinogen
66%
Fibrosis
66%
Immunoglobulin Enhancer Binding Protein
100%
Inflammation
66%
Kidney Disease
100%
Receptor
66%
Scar Formation
100%
Transcription Factors
66%
Transforming Growth Factor
66%